Sources & citations
This site is based on peer-reviewed research, clinical guidelines, and expert consensus. All major claims are traceable to the sources below.
Diagnostic criteria & guidelines
Diagnostic criteria for ADHD including the three presentations, symptom thresholds, and age of onset requirements.
UK clinical guideline covering diagnosis, medication, and non-pharmacological treatment across all ages.
Landmark consensus paper summarising the evidence base for ADHD across genetics, neuroscience, diagnosis, and treatment.
Argues for the clinical and neuropsychological distinction between inattentive and combined presentations.
Neuroscience & mechanisms
Comprehensive clinical reference covering neuropsychology, assessment, and treatment of ADHD across the lifespan.
Neuroimaging study documenting dopamine reward pathway differences in ADHD, including reduced dopamine release and receptor availability in striatal and prefrontal regions.
Treatment & interventions
Clinical review of stimulant and non-stimulant medication options, efficacy, and safety profiles.
RCT demonstrating efficacy of ADHD-adapted CBT as an add-on to medication in adults.
Summarises research on the neurobiological mechanisms by which aerobic exercise improves ADHD symptoms.
Lifespan & prevalence
Reviews developmental trajectories of ADHD from childhood through adulthood.
Population study estimating 4.4% adult ADHD prevalence; highlights impairment in work, family, and social function.
Sex & gender differences
Reviews evidence on sex differences in ADHD presentation, diagnosis rates, and impact on quality of life.
Documents how oestrogen fluctuations across the menstrual cycle, pregnancy, and menopause interact with ADHD symptoms.
Comorbidities & emotional regulation
Reviews the neurobiological basis of emotional dysregulation in ADHD and its clinical implications.